Results 291 to 300 of about 39,064 (303)

The Concept of Biosimilars: From Characterization to Evolution—A Narrative Review

Oncologist, 2018
D Sammel, A Sapronov, Wungki Park
exaly  

Biosimilars in immune‐mediated inflammatory diseases: initial lessons from the first approved biosimilar anti‐tumour necrosis factor monoclonal antibody

Journal of Internal Medicine, 2016
Edward Keystone
exaly  

Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review

Frontiers in Pharmacology, 2020
Hui-yao Huang, Yue Yu, Le Wang
exaly  

Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases

Annals of the Rheumatic Diseases, 2018
Jonathan Kay, Paul Emery, Tore K Kvien
exaly  

Medical specialists' attitudes to prescribing biosimilars

Pharmacoepidemiology and Drug Safety, 2017
A G Fraser, Nicola Dalbeth, Paul Jarrett
exaly  

Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America

Journal of Dermatology, 2017
C De La Cruz, Ricardo Romiti, Yuangang Wang   +2 more
exaly  

Nocebo in Biosimilars and Generics in Neurology: A Systematic Review

Frontiers in Pharmacology, 2019
Ioanna Spanou, Theodoros Mavridis, Dimos D Mitsikostas   +2 more
exaly  

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

Advances in Therapy, 2016
Robert Popovian
exaly  

The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars

Oncologist, 2018
Jennifer R Brown, Li Wang
exaly  

American Society of Clinical Oncology Statement: Biosimilars in Oncology

Journal of Clinical Oncology, 2018
Gary H Lyman, Anne S Tsao, Richard L Schilsky   +2 more
exaly